| Literature DB >> 16722551 |
Stephan A Padosch1, Dirk W Lachenmeier, Lars U Kröner.
Abstract
Absinthe, a bitter spirit containing wormwood (Artemisia absinthium L.), was banned at the beginning of the 20th century as consequence of its supposed unique adverse effects. After nearly century-long prohibition, absinthe has seen a resurgence after recent de-restriction in many European countries. This review provides information on the history of absinthe and one of its constituent, thujone. Medical and toxicological aspects experienced and discovered before the prohibition of absinthe are discussed in detail, along with their impact on the current situation. The only consistent conclusion that can be drawn from those 19th century studies about absinthism is that wormwood oil but not absinthe is a potent agent to cause seizures. Neither can it be concluded that the beverage itself was epileptogenic nor that the so-called absinthism can exactly be distinguished as a distinct syndrome from chronic alcoholism.The theory of a previous gross overestimation of the thujone content of absinthe may have been verified by a number of independent studies. Based on the current available evidence, thujone concentrations of both pre-ban and modern absinthes may not have been able to cause detrimental health effects other than those encountered in common alcoholism. Today, a questionable tendency of absinthe manufacturers can be ascertained that use the ancient theories of absinthism as a targeted marketing strategy to bring absinthe into the spheres of a legal drug-of-abuse. Misleading advertisements of aphrodisiac or psychotropic effects of absinthe try to re-establish absinthe's former reputation. In distinction from commercially manufactured absinthes with limited thujone content, a health risk to consumers is the uncontrolled trade of potentially unsafe herbal products such as absinthe essences that are readily available over the internet.Entities:
Year: 2006 PMID: 16722551 PMCID: PMC1475830 DOI: 10.1186/1747-597X-1-14
Source DB: PubMed Journal: Subst Abuse Treat Prev Policy ISSN: 1747-597X
Figure 1Wormwood, Artemisia absinthium L., drawing of plant, flowers, seeds and fruits (drawing by W. Müller, 1885 reproduced from Thomé [106]). Wormwood is the characteristic aromatic component of absinthe.
Figure 2Vincent van Gogh: Still Life with absinthe (Paris 1887). The picture shows one of the countless cafés in Paris, in which absinthe was served. Next to the glass filled with absinthe, a water bottle is illustrated, which was necessary for drinking ritual.
Figure 3Structure of α- und β-thujone, the principal components of wormwood oil (Artemisia absinthium L.).
Main acute and chronic effects of absinthe reported in the 19th century
| vertigo | mania |
| seizures | softening of the brain |
| nervous debility | general paralysis |
| hallucinatory delirium | psychosis |
Comparative table between symptoms of absinthism and alcoholism according to animal experiments of Amory (1868) [38].
| Animal perfectly well for fifteen minutes, at the least after the ingestion; with the exception of a few muscular twichings and a slight uneasiness. | In a very few minutes symptoms of inebriation resulting in torpor. |
| Musuclar agitation, commencing in the anterior portion of the body. | Paralysis, commencing in posterior extremities, and then extending to the anterior. |
| No paralysis. | Paralysis of both posterior and anterior extremities in succession. |
| Epileptiform convulsions and rigidity, resulting in a rapid death. | No convulsions. Stupor, coma, resolution and a gradual death. |
| No apparent lesion, except, perhaps a slight cerebral congestion, showing the cause of death to be intoxication of the poison. | Lesions of the brain and of the alimentary canal; gastritis and enteritis might have supervened, had the animals lived long enough for their development |
Summary of data about toxicology of thujone
| Toxicity data | Reference | |
| oral LD50 in rats | 192 mg/kg bw | [66] |
| oral LD50 in rats | 500 mg/kg bw | [107] |
| iv LD50 in rabbits | 0.031 mg/kg bw | [107] |
| NOEL for convulsions in rats | 12.5 mg/kg bw (males) | [108] |
| NOEL for convulsions in rats | 5 mg/kg bw (females), 10 mg/kg bw (males) | [66] |
| NOEL for convulsions in rats | 5 mg/kg bw | [66] |
| TDI (based on NOEL with safety factor of 500) | 10 μg/kg bw/d | [66] |
| Metabolism | 2-,4-, and 7-hydroxylation | [75,76] |
| Mechanism of toxicity | GABA Type A modulation (α-thujone neurotoxicity, convulsant effects) | [72,74,76] |
| Mechanism of toxicity | Porphyrogenicity (determined in cultures of chick embryo liver cells) | [46] |
| Behavioral effects | 5-HT3 receptor modulation, but no conclusive evidence for psychotropic actions of thujone | [77] |